Drug Recall

A class action in British Columbia Supreme Court claims Teva Canada, Sandoz Canada, et al. failed to warn patients prescribed Valsartan (hydrochlorothiazide) for hypertension that the drug was recalled as possibly carcinogenic, possibly because of contamination by its Chinese supplier.

VANCOUVER, B.C. — A class action in British Columbia Supreme Court claims Teva Canada, Sandoz Canada, et al. failed to warn patients prescribed Valsartan (hydrochlorothiazide) for hypertension that the drug was recalled as possibly carcinogenic , possibly because of contamination by its Chinese supplier.

Categories / Consumers, Health

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.